US › Healthcare

Delcath Systems Inc (DCTH)

US · Healthcare · Medical Devices

$16.25+0.18%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$29.1M

Revenue YoY

+20.6%

Net profit

$2.7M

Profit YoY

-1.1%

EPS

$0.07

EPS estimate

$-0.16

Net margin

9.2%

EPS came in at 0.07 against a street estimate of -0.16 — a beat of 143.8%.

Key statistics

Market cap

$548.2M

P/E

1,580.0

Forward P/E

227.3

P/B

4.58

Book value

$3.50

EPS (TTM)

$0.01

52-week high

$17.42

52-week low

$8.12

50-day MA

$14.57

200-day MA

$11.34

Beta

0.57

Analyst view

Analysts rate Delcath Systems Inc a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $24.00.

Shareholding

Insiders

8.09%

Institutions

51.70%

Largest institutional holders

Fund	Stake
Rosalind Advisors, Inc.	9.51%
BlackRock Inc	5.14%
Vanguard Capital Management, LLC	3.83%
Propel Bio Management LLC	2.51%
Geode Capital Management, LLC	1.99%
State Street Corp	1.91%
Millennium Management LLC	1.63%
Divisadero Street Capital Management, LP	1.44%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Delcath Systems Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.